Accueil > Les Laboratoires > CHU de Besançon > Publications de l’équipe

Les Laboratoires

Années 2017-2021


>Targeted genome reduction of Pseudomonas aeruginosa strain PAO1 led to the development of hypovirulent and hypersusceptible rDNA hosts. Grosjean M, Guénard S, Giraud C, Muller C, Plésiat P, Juarez P. Front Bioeng Biotechnol. 2021 Mar 11;9:640450.

>1,2,3-Triazole-gold(I)-triethylposphine derivatives active against resistant Gram-positive pathogens. Michaut M, Steffen A, Contreras JM, Morice C, Schalk IJ, Plésiat P, Mislin. GLA. Bioorg Med Chem Lett. 2021 Feb 24;40:127879.

>Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019. Lötsch F, Albiger B, Monnet DL, Struelens MJ, Seifert H, Kohlenberg A; European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net). Euro Surveill. 2020 Nov;25(45):2001735.

>Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Garrigos T, Neuwirth C, Chapuis A, Bador J, Amoureux L; Collaborators. Clin Microbiol Infect. 2021 Jan;27(1):126.e1-126.e5.

>Involvement of the Pseudomonas aeruginosa MexAB-OprM efflux pump in the secretion of the metallophore pseudopaline. Gomez NO, Tetard A, Ouerdane L, Laffont C, Brutesco C, Ball G, Lobinski R, Denis Y, Plésiat P, Llanes C, Arnoux P, Voulhoux. R. Mol Microbiol. 2021 Jan;115(1):84-98.

>Coordinate overexpression of two RND efflux systems, ParXY and TtgABC, is responsible for multidrug resistance in Pseudomonas putida. Puja H, Comment G, Chassagne S, Plésiat P, Jeannot K. Environ Microbiol. 2020. 10.1111/1462-2920.15200.

>The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties. Roblin C, Chiumento S, Bornet O, Nouailler M, Müller CS, Jeannot K, Basset C, Kieffer-Jaquinod S, Couté Y, Torelli S, Le Pape L, Schünemann V, Olleik H, De La Villeon B, Sockeel P, Di Pasquale E, Nicoletti C, Vidal N, Poljak L, Iranzo O, Giardina T, Fons M, Devillard E, Polard P, Maresca M, Perrier J, Atta M, Guerlesquin F, Lafond M, Duarte V.Proc Natl Acad Sci U S A. 2020 Aug 11117(32):19168-19177. 

>Chryso-lactams:Gold(I) derivatives of ampicillin with specific activity against Gram-positive pathogens. Michaut M, Steffen A, Contreras JM, Morice C, Paulen A, Schalk IJ, Plésiat P, Mislin GLA. Bioorg Med Chem Lett. 2020 May 130(9):127098. 

>The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin. Puja H, Bolard A, Noguès A, Plésiat P, Jeannot K. Antimicrob Agents Chemother. 2020 Mar 2464(4):e02033-19. 

>A Standard Numbering Scheme for Class C β-Lactamases. Mack AR, Barnes MD, Taracila MA, Hujer AM, Hujer KM, Cabot G, Feldgarden M, Haft DH, Klimke W, van den Akker F, Vila AJ, Smania A, Haider S, Papp-Wallace KM, Bradford PA, Rossolini GM, Docquier JD, Frère JM, Galleni M, Hanson ND, Oliver A, Plésiat P, Poirel L, Nordmann P, Palzkill TG, Jacoby GA, Bush K, Bonomo RA. Antimicrob Agents Chemother. 2020 Feb 2164(3):e01841-19. 

>Local outbreak of extended- spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone. Royer G, Fourreau F, Boulanger B, Mercier-Darty M, Ducellier D, Cizeau F, Potron A, Podglajen I, Mongardon N, Decousser JW. J Hosp Infect. 2020 Jan;104(1):33-39.

>The Transcriptional Repressor SmvR Is Important for Decreased Chlorhexidine Susceptibility in Enterobacter cloacae Complex. Guérin F, Gravey F, Plésiat P, Aubourg M, Beyrouthy R, Bonnet R, Cattoir V, Giard JC.Antimicrob Agents Chemother. 2019 Dec 2064(1):e01845-19. doi: 10.1128/AAC.01845-19. Print 2019 Dec 20.

>Acquisition of class C β-lactamase PAC-1 by ST664 strains of Pseudomonas aeruginosa. Bour M, Fournier D, Jové T, Pouzol A, Miltgen G, Janvier F, Jeannot K, Plésiat P. Antimicrob Agents Chemother. 2019 Sep 1663(12):e01375-19.

>Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance. Sun D, Jeannot K, Xiao Y, Knapp CW. Front Microbiol. 2019 Aug 2710:1933.

>Production of Norspermidine Contributes to Aminoglycoside Resistance in pmrAB Mutants of Pseudomonas aeruginosaBolard A, Schniederjans M, Haüssler S, Triponney P, Valot B, Plésiat P, Jeannot K. Antimicrob Agents Chemother. 2019 Sep 2363(10):e01044-19. 

>Cinnamaldehyde Induces Expression of Efflux Pumps and Multidrug Resistance in Pseudomonas aeruginosa. Tetard A, Zedet A, Girard C, Plésiat P, Llanes C.Antimicrob Agents Chemother. 2019 Sep 2363(10):e01081-19. 

>An unusual community-acquired invasive and multi systemic infection due to ExoU-harboring Pseudomonas aeruginosa strain: Clinical disease and microbiological characteristics. Elabbadi A, Pont S, Verdet C, Plésiat P, Cretin F, Voiriot G, Fartoukh M, Djibré M.J Microbiol Immunol Infect. 2020 Aug53(4):647-651. 

>Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters. Potron A, Fournier D, Emeraud C, Triponney P, Plésiat P, Naas T, Dortet L. Antimicrob Agents Chemother. 2019 Aug 2363(9):e00968-19. 

>ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin. Potron A, Vuillemenot JB, Puja H, Triponney P, Bour M, Valot B, Amara M, Cavalié L, Bernard C, Parmeland L, Reibel F, Larrouy-Maumus G, Dortet L, Bonnin RA, Plésiat P.J Antimicrob Chemother. 2019 Sep 174(9):2544-2550. 

>Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community. Potron A, Hocquet D, Triponney P, Plésiat P, Bertrand X, Valot B.Antimicrob Agents Chemother. 2019 May 24;63(6):e00191-19.

>In vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis. Vu TH, Ha-Duong NT, Aubry A, Capton E, Fechter P, Plésiat P, Verbeke P, Serradji N. Bioorg Chem. 2019 Mar;83:180-185.

>Identification of Diverse Integron and Plasmid Structures Carrying a Novel Carbapenemase Among Pseudomonas Species. Liapis E, Bour M, Triponney P, Jové T, Zahar JR, Valot B, Jeannot K, Plésiat P. Front Microbiol. 2019 Mar 410:404. 

>Sequential emergence of colistin and rifampicin resistance in an OXA-72- producing outbreak strain of Acinetobacter baumanniiPotron A, Bour M, Triponney P, Muller J, Koebel C, A Bonnin R, Plésiat P.Int J Antimicrob Agents. 2019 May53(5):669-673. 

>Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry. Vongthilath R, Richaud Thiriez B, Dehillotte C, Lemonnier L, Guillien A, Degano B, Dalphin ML, Dalphin JC, Plésiat P.PLoS One. 2019 Jan 814(1):e0210201. 

>Azetidine-Containing Alkaloids Produced by a Quorum-Sensing Regulated Nonribosomal Peptide Synthetase Pathway in Pseudomonas aeruginosa. Hong Z, Bolard A, Giraud C, Prévost S, Genta-Jouve G, Deregnaucourt C, Häussler S, Jeannot K, Li Y. Angew Chem Int Ed Engl. 2019 Mar 458(10):3178-3182. 

>Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria. Dortet L, Potron A, Bonnin RA, Plesiat P, Naas T, Filloux A, Larrouy-Maumus G.Sci Rep. 2018 Nov 158(1):16910. 

>Higher Prevalence of PldA, a Pseudomonas aeruginosa Trans-Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains. Boulant T, Boudehen YM, Filloux A, Plesiat P, Naas T, Dortet L. Front Microbiol. 2018 Oct 299:2578. 

>A novel IncQ plasmid carrying gene blaCTX-M-3 in Pseudomonas aeruginosa. Jeannot K, Danassie M, Triponney P, Bour M, Gueudet T, Beyrouthy R, Bonnet R, Plésiat P.J Antimicrob Chemother. 2019 Mar 174(3):823-825. 

>A case of leech-associated infection involving an extended-spectrum β-lactamase-producing and extensively drug-resistant Aeromonas hydrophila. Floug Q, Sinna R, Fillatre A, Plésiat P, Hamdad F. Clin Microbiol Infect. 2019 Mar;25(3):394-395.

>Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. Dortet L, Bonnin RA, Pennisi I, Gauthier L, Jousset AB, Dabos L, Furniss RCD, Mavridou DAI, Bogaerts P, Glupczynski Y, Potron A, Plesiat P, Beyrouthy R, Robin F, Bonnet R, Naas T, Filloux A, Larrouy-Maumus G. J Antimicrob Chemother. 2018 Dec 173(12):3359-3367. 

>Constitutive Activation of MexT by Amino Acid Substitutions Results in MexEF-OprN Overproduction in Clinical Isolates of Pseudomonas aeruginosaJuarez P, Broutin I, Bordi C, Plésiat P, Llanes C.Antimicrob Agents Chemother. 2018 Apr 2662(5):e02445-17. 

>Analysis of OXA-204 carbapenemase-producing Enterobacteriaceae reveals possible endoscopy-associated transmission, France, 2012 to 2014. Potron A, Bernabeu S, Cuzon G, Pontiès V, Blanchard H, Seringe E, Naas T, Nordmann P, Dortet L.Euro Surveill. 2017 Dec22(49):17-00048. 

>Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa. Bolard A, Plésiat P, Jeannot K.Antimicrob Agents Chemother. 2018 Jan 2562(2):e01835-17. 

>CTX-M-15-Producing Shewanella Species Clinical Isolate Expressing OXA-535, a Chromosome-Encoded OXA-48 Variant, Putative Progenitor of the Plasmid-Encoded OXA-436. Jousset AB, Dabos L, Bonnin RA, Girlich D, Potron A, Cabanel N, Dortet L, Glaser P, Naas T.Antimicrob Agents Chemother. 2017 Dec 2162(1):e01879-17. 

>Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems. Haenni M, Bour M, Châtre P, Madec JY, Plésiat P, Jeannot K. Front Microbiol. 2017 Sep 298:1847. 

>Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients. Mustafa MH, Khandekar S, Tunney MM, Elborn JS, Kahl BC, Denis O, Plésiat P, Traore H, Tulkens PM, Vanderbist F, Van Bambeke F.Eur Respir J. 2017 May 1949(5):1601847. 

>Toxic Electrophiles Induce Expression of the Multidrug Efflux Pump MexEF-OprN in Pseudomonas aeruginosa through a Novel Transcriptional Regulator, CmrA. Juarez P, Jeannot K, Plésiat P, Llanes C.Antimicrob Agents Chemother. 2017 Jul 2561(8):e00585-17. 

>Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder. Dinh A, Davido B, Calin R, Paquereau J, Duran C, Bouchand F, Phé V, Chartier-Kastler E, Rottman M, Salomon J, Plésiat P, Potron A. Spinal Cord Ser Cases. 2017 May 113:17019. 

>Resistance to polymyxins in Gram-negative organisms. Jeannot K, Bolard A, Plésiat P. Int J Antimicrob Agents. 2017 May49(5):526-535. 

>Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic. Chalhoub H, Pletzer D, Weingart H, Braun Y, Tunney MM, Elborn JS, Rodriguez-Villalobos H, Plésiat P, Kahl BC, Denis O, Winterhalter M, Tulkens PM, Van Bambeke F.Sci Rep. 2017 Jan 167:40208.